DOSSIER · 13F Holders · Q3 2025Healthcare · Biotechnology
VRNA
VERONA PHARMA PLC
4 institutions still hold VERONA PHARMA PLC as of Q3 2025. Tracked across SEC 13F-HR filings, with insider and 13D/G activity surfaced alongside.
CUSIP 925050106·Biotechnology·4 13F holders·last filed Sep 30, 2025
AI Holders Summary · Q3 2025
4 institutions reported VRNA in Q3 2025. Burren Capital Advisors Ltd leads at 69.5% of the visible book.
Top holders
Sorted by position value. Source: SEC EDGAR 13F-HR filings.